Related Experiment Video
Updated: Jun 6, 2026

07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Converging micro-nano-bio technologies towards integrated in-vitro testing systems: Current activities and future
1European Commission, Information Society and Media Directorate-General, Brussels, Belgium.
Summary
Micro-Nano-Bio Systems (MNBS) integrate information, communication, and bio-technologies for advanced healthcare solutions. This research focuses on miniaturized in-vitro testing systems, like lab-on-chips, to improve well-being and address healthcare challenges.
Area of Science:
- Convergence of Information & Communication Technologies (ICT), Micro-Nano Technologies, and Bio-Technologies.
- Development of miniaturized, smart, and integrated systems for healthcare applications.
- Focus on Micro-Nano-Bio Systems (MNBS) for in-vitro diagnostics and human-interactive technologies.
Background:
- Emerging MNBS are poised to impact healthcare, the ageing population, and overall well-being.
- European Union's R&D programs prioritize ICT for MNBS development.
- MNBS applications include in-vitro testing (lab-on-chips) and human-interactive systems (implants, surgical robotics).
Purpose of the Study:
- To present background information on MNBS in-vitro testing for a mini-symposium.
- To discuss current challenges, solutions, and open issues in MNBS technology.
- To highlight the integration of technology building blocks into smart, miniaturized systems.
Main Methods:
- Research and development of technology building blocks for in-vitro testing.
- Focus on sample preparation, ultra-sensitive detection, molecular recognition chemistry, and microfluidics.
- Integration of these components into advanced systems like biochips and Lab on Chip devices.
Main Results:
- Development of miniaturized systems for in-vitro testing, including DNA & protein arrays, biochips, Lab on Chip, and Lab on Card.
- Advancements in technology building blocks such as sample preparation and detection techniques.
- Progress in integrating microfluidics and molecular recognition for enhanced diagnostic capabilities.
Conclusions:
- MNBS in-vitro testing holds significant promise for healthcare advancements.
- Continued research is needed to overcome challenges and meet technological and socioeconomic demands.
- The presented work provides foundational insights for the mini-symposium on MNBS in-vitro testing.
Related Concept Videos
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...

